Skip to main content

OmniAb, Inc. (OABI) Stock Forecast

Data as of Sep 20, 2026

Healthcare · Current price $4.38 (-1.24%)

Consensus Target
$4.00
Upside
-8.8%
Analysts
1
Rating
Buy(2.00)

Price Target Range

Low $4.00High $4.00

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

OABI vs Sector & Market

MetricOABIHealthcare AvgLarge Cap Avg
Analyst Rating2.002.262.42
Analyst Count1818
Target Upside-8.8%+22243.7%+21.5%
P/E Ratio-2.763.7638.34

Revenue Estimates

PeriodLowAvgHigh#
2026-09-30$5M$7M$8M2
2026-12-31$7M$9M$11M2
2027-03-31$6M$8M$9M2
2027-06-30$6M$9M$10M2
2027-09-30$6M$9M$10M2
2027-12-31$7M$10M$11M2
2028-12-31$54M$72M$104M4
2029-12-31$70M$95M$136M3
2030-12-31$86M$116M$168M3

EPS Estimates

PeriodLowAvgHigh#
2026-09-30$-0.12$-0.10$-0.061
2026-12-31$-0.11$-0.09$-0.061
2027-03-31$-0.12$-0.10$-0.061
2027-06-30$-0.12$-0.10$-0.061
2027-09-30$-0.12$-0.10$-0.061
2027-12-31$-0.12$-0.10$-0.061
2028-12-31$-0.12$-0.06$-0.013
2029-12-31$0.02$0.04$0.061
2030-12-31$0.08$0.12$0.191

Frequently Asked Questions

What is the analyst consensus for OABI?

The consensus among 1 analysts covering OmniAb, Inc. (OABI) is Buy with an average price target of $4.00.

What is the highest price target for OABI?

The highest analyst price target for OABI is $4.00.

What is the lowest price target for OABI?

The lowest analyst price target for OABI is $4.00.

How many analysts cover OABI?

1 analysts have issued ratings for OmniAb, Inc. in the past 12 months.

Is OABI a buy or sell right now?

Based on 1 analyst ratings, OABI has a consensus rating of Buy (2.00/5) with a -8.8% upside to the consensus target of $4.00.

What are the earnings estimates for OABI?

Analysts estimate OABI will report EPS of $-0.10 for the period ending 2026-09-30, with revenue estimated at $7M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.